Efficacy and Safety of MOX/ALB Co-administration in SAC
Conditions: Trichuriasis; Ascariasis; Hookworm Infections Interventions: Drug: Moxidectin 2 mg Oral Tablet; Drug: Albendazole 400 mg Oral Tablet; Drug: Placebo MOX; Drug: Placebo ALB Sponsors: Jennifer Keiser; Public Health Laboratory Ivo de Carneri Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
Conditions: Trichuriasis; Ascariasis; Hookworm Infections Interventions: Drug: Ivermectin 1.5 mg ODT; Drug: Ivermectin 3 mg Oral Tablet; Drug: Albendazole 400 mg Oral Tablet; Drug: Placebo IVM ODT Sponsors: Jennifer Keiser; Public Health Laboratory Ivo de Carneri Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of MOX/ALB Co-administration
Conditions: Trichuriasis; Ascariasis; Hookworm Infections Interventions: Drug: Moxidectin 2 mg Oral Tablet; Drug: Albendazole 400 mg Oral Tablet; Drug: Ivermectin 3 mg Oral Tablet Sponsors: Jennifer Keiser; Centre Suisse de Recherches Scientifiques en Cote d'Ivoire Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2021 Category: Research Source Type: clinical trials
Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration
Conditions: Trichuriasis; Ascariasis; Hookworm Infections; Helminthes; Infestation, Intestinal Interventions: Drug: moxidectin (8 mg) / albendazole (400 mg); Drug: ivermectin (200 µg/kg) / albendazole (400 mg); Drug: ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL]; Drug: ivermectin (200 µg/kg); Drug: moxidectin (8 mg) Sponsors: Jennifer Keiser; Public Health Laboratory Ivo de Carneri, Chake Chake, Pemba, Zanzibar, Tanzania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2021 Category: Research Source Type: clinical trials
